HC Wainwright Weighs in on Rockwell Medical, Inc.’s Q4 2024 Earnings (NASDAQ:RMTI)

Rockwell Medical, Inc. (NASDAQ:RMTI) – Analysts at HC Wainwright reduced their Q4 2024 earnings per share (EPS) estimates for Rockwell Medical in a report released on Monday, March 25th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.01) per share for the quarter, down from their prior forecast of $0.01. HC Wainwright has a “Buy” rating and a $9.00 price target on the stock. The consensus estimate for Rockwell Medical’s current full-year earnings is ($0.11) per share. HC Wainwright also issued estimates for Rockwell Medical’s FY2025 earnings at $0.06 EPS.

Rockwell Medical Stock Down 0.6 %

Rockwell Medical stock opened at $1.64 on Tuesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.38 and a current ratio of 1.73. The firm has a market capitalization of $48.10 million, a price-to-earnings ratio of -4.10 and a beta of 1.16. Rockwell Medical has a fifty-two week low of $1.16 and a fifty-two week high of $6.24. The stock’s fifty day moving average is $1.41 and its two-hundred day moving average is $1.71.

Institutional Trading of Rockwell Medical

Several large investors have recently bought and sold shares of RMTI. Renaissance Technologies LLC grew its holdings in Rockwell Medical by 24.7% in the first quarter. Renaissance Technologies LLC now owns 281,234 shares of the company’s stock valued at $133,000 after purchasing an additional 55,700 shares during the last quarter. Jane Street Group LLC purchased a new stake in shares of Rockwell Medical in the third quarter valued at $28,000. Armistice Capital LLC lifted its position in shares of Rockwell Medical by 26.2% in the fourth quarter. Armistice Capital LLC now owns 1,210,076 shares of the company’s stock valued at $1,228,000 after acquiring an additional 251,076 shares in the last quarter. Millennium Management LLC lifted its position in shares of Rockwell Medical by 66.7% in the fourth quarter. Millennium Management LLC now owns 53,044 shares of the company’s stock valued at $54,000 after acquiring an additional 21,225 shares in the last quarter. Finally, State Street Corp lifted its position in shares of Rockwell Medical by 94.2% in the first quarter. State Street Corp now owns 33,604 shares of the company’s stock valued at $61,000 after acquiring an additional 16,300 shares in the last quarter. Institutional investors and hedge funds own 23.31% of the company’s stock.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.